UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CFI 607/2025

Jul 8, 2025·EP4241767: NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Parent infringement case:UPC CFI 192/2025

Case details
Status
Interim Phase
Action
Counterclaim for revocation
Category
Counter Claim for Revocation
Parties
Claimants
Reps: Kilian Seidel
Respondents
Reps: Eveline Lots; Hendrik Lambers; Koen Bijvank; Lilia Bouzoraa; Mark van Gardingen
Division
The Hague LD
Judges
Technology
Biotech · mRNA Delivery · Biotechnology
Language
English
Documents
Document titleDatePublic
Hearing recording reference document2026-03-09Not public
Receipt2026-03-04Not public
Cover sheet2026-03-04Not public
Application document Defendant2026-03-04Not public
Receipt2026-02-27Not public
Cover sheet2026-02-27Not public
Document Claimant2026-02-27Not public
action.communication.general2026-02-27Not public
Receipt2026-02-26Not public
Cover sheet2026-02-26Not public
Fee2026-02-26Not public
Application document Claimant2026-02-26Not public
Receipt2026-02-19Not public
Cover sheet2026-02-19Not public
Exhibit Claimant2026-02-19Not public
Exhibit Claimant2026-02-19Not public
action.issueOrder.order2026-02-12Not public
Order2026-02-12Public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Defendant2026-01-21Not public
Receipt2026-01-21Not public
Cover sheet2026-01-21Not public
Other document Defendant2026-01-21Not public
action.phaseChange.interimPhaseOpen2026-01-14Not public
action.phaseChange.writtenPhaseClose2026-01-14Not public
Receipt2026-01-12Not public
Cover sheet2026-01-12Not public
Statement of rejoinder2026-01-12Not public
Exhibit document Defendant2026-01-12Not public
Exhibit document Defendant2026-01-12Not public
Exhibit document Defendant2026-01-12Not public
action.issueOrder.order2025-12-23Not public
Order2025-12-23Not public
Cover sheet2025-12-18Not public
Further pleadings2025-12-18Not public
Receipt2025-12-18Not public
Cover sheet2025-12-16Not public
Exhibit document Defendant2025-12-16Not public
Exhibit document Defendant2025-12-16Not public
Receipt2025-12-16Not public
action.communication.general2025-12-16Not public
Cover sheet2025-12-15Not public
Further pleadings2025-12-15Not public
Receipt2025-12-15Not public
action.communication.general2025-12-11Not public
Cover sheet2025-12-10Not public
Exhibit document Defendant2025-12-10Not public
Exhibit document Defendant2025-12-10Not public
Exhibit document Defendant2025-12-10Not public
Counterclaim rejoinder2025-12-10Not public
Receipt2025-12-10Not public
Cover sheet2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Exhibit document Claimant2025-11-10Not public
Counterclaim reply2025-11-10Not public
Application to Amend Patent Defence2025-11-10Not public
Receipt2025-11-10Not public
Panel-Appointment2025-09-17Not public
Acknowledgement-of-lodging2025-09-11Not public
Formal-checks_Notification-of-positive-outcome2025-09-11Not public
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio2025-09-10Not public
Exhibit A091 - EP 767 Claim requests (clean version)2025-09-10Not public
Exhibit A102 - US 61/242,761 - FBD-T 63 P32025-09-10Not public
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis2025-09-10Not public
Exhibit A106 - US 61/222,464 - FBD-T 67 P12025-09-10Not public
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration2025-09-10Not public
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharm2025-09-10Not public
Exhibit A118 - Moderna IT webpage2025-09-10Not public
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)2025-09-10Not public
Exhibit A116 - Moderna ES supply invoicing EU states2025-09-10Not public
Exhibit A101 - US 61/234,045 - FBD-T 63 P22025-09-10Not public
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o2025-09-10Not public
Exhibit A115 - Arbutus Genevant CLA 2018 SEC2025-09-10Not public
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid2025-09-10Not public
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery2025-09-10Not public
Exhibit A092 - EP 767 Claim requests (tracked changes version)2025-09-10Not public
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery2025-09-10Not public
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids2025-09-10Not public
Exhibit A108 - US 61/231,579 - FBD-T 62 P22025-09-10Not public
Exhibit A103 - US 61/251,999 - FBD-T 63 P42025-09-10Not public
Exhibit A100 - US 61/175,777 - FBD-T 63 P12025-09-10Not public
Exhibit A107 - US 61/159,788 - FBD-T 62 P12025-09-10Not public
Reply to SoD + Defence to CC + App to Amend2025-09-10Not public
Exhibit A094 - Jeffs 2005 - A Scalable Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA2025-09-10Not public
Exhibit A099 - Register extract of FBD-T 662025-09-10Not public
Exhibit A105 - US 61/222/469 - FBD-T 65 P12025-09-10Not public
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information2025-09-10Not public
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain, Moderna Switzerland and Moderna Netherlan2025-09-10Not public
Exhibit A104 - US 61/258,848 - FBD-T 63 P52025-09-10Not public
Formal-checks_Notification-of-positive-outcome2025-09-10Not public
Acknowledgement-of-lodging2025-09-10Not public
Exhibit A096 - Song 1997 - Characterization of Cationic liposome-mediated Transfer In Vivo by Intravenous Administration2025-09-10Not public
Exhibit A091 - EP 767 Claim requests (clean version)2025-09-10Not public
Exhibit A103 - US 61-251.999 - FBD-T 63 P42025-09-10Not public
Exhibit A092 - EP 767 Claim requests (tracked changes version)2025-09-10Not public
Exhibit A102 - US 61-242.761 - FBD-T 63 P32025-09-10Not public
Reply to SoD + Defence to CC + App to Amend2025-09-10Not public
Exhibit A094 - Jeffs 2005 - A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA2025-09-10Not public
Exhibit A104 - US 61-258.848 - FBD-T 63 P52025-09-10Not public
Exhibit A100 - US 61-175.777 - FBD-T 63 P12025-09-10Not public
Exhibit A098 - Prof. Dr. Ir. De Geest declaration (including annexes)2025-09-10Not public
Exhibit A097 - Sabnis 2018 - A novel amino lipid series for mRNA delivery - improved endosomal escape and sustained phar2025-09-10Not public
Exhibit A095 - Bajaj 2007 - Effect of the headgroup variation on the gene transfer properties of cholesterol based catio2025-09-10Not public
Exhibit A109 - Semple 2010 - Rational design of cationic lipids for siRNA delivery2025-09-10Not public
Exhibit A107 - US 61-159.788 - FBD-T 62 P12025-09-10Not public
Exhibit A101 - US 61-234.045 - FBD-T 63 P22025-09-10Not public
Exhibit A112 - Coelho 2013 - Safety and efficacy of RNAi therapy for transthyretin amyloidosis2025-09-10Not public
Exhibit A099 - Register extract of FBD-T 662025-09-10Not public
Exhibit A105 - US 61-222.469 - FBD-T 65 P12025-09-10Not public
Exhibit A113 - Lv 2006 - Toxicity of cationic lipids and cationic polymers in gene delivery2025-09-10Not public
Exhibit A106 - US 61-222.464 - FBD-T 67 P12025-09-10Not public
Exhibit A110 - Semple 2010 - Rational design of cationic lipids for siRNA delivery - supplementary information2025-09-10Not public
Exhibit A115 - Arbutus - Genevant Cross-License Agreement 2018 (SEC version)2025-09-10Not public
Exhibit A093 - Heyes 2005 - Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids2025-09-10Not public
Exhibit A116 - Moderna Biotech Spain documentation of Spikevax supply and invoicing to EU states2025-09-10Not public
Exhibit A118 - Moderna Italy webpage2025-09-10Not public
Exhibit A114 - Maier 2013 - Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery o2025-09-10Not public
Exhibit A111 - Schlich 2021 - Cytosolic delivery of nucleic acids The case of ionizable lipid2025-09-10Not public
Exhibit A117 - Belgium trade register registrations for Moderna Biotech Spain - Moderna Switzerland and Moderna Netherla2025-09-10Not public
Exhibit A108 - US 61-231.579 - FBD-T 62 P22025-09-10Not public
Acknowledgement of access to case2025-07-29Not public
Notification Of Service2025-07-29Not public
EPO_Communication_check_Outcome2025-07-25Not public
EPO_Communication_check_Outcome2025-07-23Not public
EPO_Communication_check_Outcome2025-07-23Not public
EPO_Communication_check_Outcome2025-07-23Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-22Not public
Document from EPO2025-07-21Not public
Panel-Appointment2025-07-17Not public
EPO-Request-for-case-pending2025-07-17Not public
Acknowledgement-of-lodging2025-07-17Not public
Formal-checks_Notification-of-positive-outcome2025-07-17Not public
Exhibit FBD-T 702025-07-17Not public
Exhibit FBD-T 182025-07-17Not public
Exhibit FBD-T 272025-07-17Not public
Exhibit FBD-T 462025-07-17Not public
Exhibit FBD-T 602025-07-17Not public
Exhibit FBD-T 302025-07-17Not public
Exhibit FBD-T 62025-07-17Not public
Exhibit FBD-T 392025-07-17Not public
Exhibit FBD-T 112025-07-17Not public
Exhibit FBD-T 202025-07-17Not public
Exhibit FBD-T 72025-07-17Not public
Exhibit FBD-T 192025-07-17Not public
Exhibit FBD-T 442025-07-17Not public
Exhibit FBD-T 282025-07-17Not public
Exhibit FBD-T 212025-07-17Not public
2025-07-08_-_UPC2_EP767_Moderna_Statement_of_Defence_and_Counterclaim_for_Revocation2025-07-17Not public
Exhibit FBD-T 252025-07-17Not public
Exhibit FBD-T 372025-07-17Not public
Exhibit FBD-T 102025-07-17Not public
Exhibit FBD-T 482025-07-17Not public
Exhibit FBD-T 572025-07-17Not public
Exhibit FBD-T 642025-07-17Not public
Exhibit FBD-T 652025-07-17Not public
Exhibit FBD-T 242025-07-17Not public
Exhibit FBD-T 172025-07-17Not public
Exhibit FBD-T 422025-07-17Not public
Exhibit FBD-T 512025-07-17Not public
Exhibit FBD-T 292025-07-17Not public
Exhibit FBD-T 522025-07-17Not public
Exhibit FBD-T 672025-07-17Not public
Exhibit FBD-T 162025-07-17Not public
Exhibit FBD-T 52025-07-17Not public
Exhibit FBD-T 382025-07-17Not public
Exhibit FBD-T 262025-07-17Not public
Exhibit FBD-T 32025-07-17Not public
Exhibit FBD-T 612025-07-17Not public
Exhibit FBD-T 22025-07-17Not public
Exhibit FBD-T 152025-07-17Not public
Exhibit FBD-T 622025-07-17Not public
Exhibit FBD-T 122025-07-17Not public
Exhibit FBD-T 42025-07-17Not public
Exhibit FBD-T 402025-07-17Not public
Exhibit FBD-T 532025-07-17Not public
Exhibit FBD-T 352025-07-17Not public
Exhibit FBD-T 682025-07-17Not public
Exhibit FBD-T 342025-07-17Not public
Exhibit FBD-T 502025-07-17Not public
Exhibit FBD-T 582025-07-17Not public
Exhibit FBD-T 332025-07-17Not public
Exhibit FBD-T 82025-07-17Not public
Exhibit FBD-T 692025-07-17Not public
Exhibit FBD-T 412025-07-17Not public
Exhibit FBD-T 452025-07-17Not public
Exhibit FBD-T 362025-07-17Not public
Exhibit FBD-T 322025-07-17Not public
Exhibit FBD-T 562025-07-17Not public
Exhibit FBD-T 12025-07-17Not public
Exhibit FBD-T 472025-07-17Not public
Exhibit FBD-T 312025-07-17Not public
Exhibit FBD-T 552025-07-17Not public
Exhibit FBD-T 592025-07-17Not public
Exhibit FBD-T 492025-07-17Not public
Exhibit FBD-T 662025-07-17Not public
Exhibit FBD-T 132025-07-17Not public
Exhibit FBD-T 542025-07-17Not public
Exhibit FBD-T 432025-07-17Not public
25-07-17_-_Moderna_vs_Genevant_Arbutus_-_EP767_-_Formal_response_to_request_for_amendments_-_CC_318331_20252025-07-17Not public
Exhibit FBD-T 232025-07-17Not public
Exhibit FBD-T 142025-07-17Not public
Exhibit FBD-T 222025-07-17Not public
Exhibit FBD-T 92025-07-17Not public
Exhibit FBD-T 632025-07-17Not public
Formal-checks_Request-for-correction2025-07-10Not public
Exhibit FBD-T 462025-07-08Not public
Exhibit FBD-T 312025-07-08Not public
Exhibit FBD-T 592025-07-08Not public
Exhibit FBD-T 372025-07-08Not public
Exhibit FBD-T 222025-07-08Not public
Exhibit FBD-T 662025-07-08Not public
Exhibit FBD-T 442025-07-08Not public
Exhibit FBD-T 122025-07-08Not public
Exhibit FBD-T 542025-07-08Not public
Exhibit FBD-T 22025-07-08Not public
Exhibit FBD-T 72025-07-08Not public
Exhibit FBD-T 432025-07-08Not public
Exhibit FBD-T 92025-07-08Not public
Exhibit FBD-T 32025-07-08Not public
Exhibit FBD-T 642025-07-08Not public
Exhibit FBD-T 182025-07-08Not public
Exhibit FBD-T 392025-07-08Not public
Exhibit FBD-T 692025-07-08Not public
Exhibit FBD-T 382025-07-08Not public
Exhibit FBD-T 582025-07-08Not public
Exhibit FBD-T 342025-07-08Not public
Exhibit FBD-T 682025-07-08Not public
Exhibit FBD-T 472025-07-08Not public
Exhibit FBD-T 292025-07-08Not public
Exhibit FBD-T 412025-07-08Not public
Exhibit FBD-T 502025-07-08Not public
Exhibit FBD-T 212025-07-08Not public
Exhibit FBD-T 562025-07-08Not public
Exhibit FBD-T 272025-07-08Not public
Exhibit FBD-T 242025-07-08Not public
Exhibit FBD-T 62025-07-08Not public
Exhibit FBD-T 422025-07-08Not public
Exhibit FBD-T 262025-07-08Not public
Exhibit FBD-T 352025-07-08Not public
Exhibit FBD-T 152025-07-08Not public
Exhibit FBD-T 652025-07-08Not public
Exhibit FBD-T 482025-07-08Not public
Exhibit FBD-T 202025-07-08Not public
Exhibit FBD-T 402025-07-08Not public
Exhibit FBD-T 362025-07-08Not public
Exhibit FBD-T 622025-07-08Not public
Exhibit FBD-T 232025-07-08Not public
Exhibit FBD-T 102025-07-08Not public
Exhibit FBD-T 522025-07-08Not public
Exhibit FBD-T 512025-07-08Not public
Exhibit FBD-T 702025-07-08Not public
Exhibit FBD-T 322025-07-08Not public
Exhibit FBD-T 82025-07-08Not public
Exhibit FBD-T 192025-07-08Not public
Exhibit FBD-T 12025-07-08Not public
Exhibit FBD-T 492025-07-08Not public
Exhibit FBD-T 252025-07-08Not public
Exhibit FBD-T 332025-07-08Not public
Exhibit FBD-T 612025-07-08Not public
Exhibit FBD-T 672025-07-08Not public
Exhibit FBD-T 42025-07-08Not public
Exhibit FBD-T 162025-07-08Not public
Exhibit FBD-T 572025-07-08Not public
Exhibit FBD-T 602025-07-08Not public
Exhibit FBD-T 112025-07-08Not public
Exhibit FBD-T 282025-07-08Not public
Exhibit FBD-T 632025-07-08Not public
Exhibit FBD-T 532025-07-08Not public
Exhibit FBD-T 552025-07-08Not public
Exhibit FBD-T 302025-07-08Not public
Exhibit FBD-T 452025-07-08Not public
Exhibit FBD-T 172025-07-08Not public
EP 767 - Moderna Statement of Defence and Counterclaim for Revocation2025-07-08Not public
Exhibit FBD-T 132025-07-08Not public
Exhibit FBD-T 142025-07-08Not public
Exhibit FBD-T 52025-07-08Not public